10.6084/m9.figshare.5720029.v1 Jamil Alli Murad Junior Jamil Alli Murad Junior Maurício Nassau Machado Maurício Nassau Machado Marcio Pimentel Fernandes Marcio Pimentel Fernandes Marcelo José Ferreira Soares Marcelo José Ferreira Soares Ingrid Helen Grigolo Ingrid Helen Grigolo Cristiane Carvalho Singulane Cristiane Carvalho Singulane Moacir Fernandes de Godoy Moacir Fernandes de Godoy B-Type Natriuretic Peptide as a Predictor of Short-Term Mortality in On-Pump Coronary Artery Bypass Grafting SciELO journals 2017 Natriuretic Peptides Coronary Artery Bypass Prospective Studies 2017-12-20 02:58:56 Dataset https://scielo.figshare.com/articles/dataset/B-Type_Natriuretic_Peptide_as_a_Predictor_of_Short-Term_Mortality_in_On-Pump_Coronary_Artery_Bypass_Grafting/5720029 <div><p>Abstract Objective: The present study refers to a determination of the preoperative B-type natriuretic peptide is a predictor of short-term all-cause mortality in patients undergoing on-pump coronary artery bypass graft surgeries. Methods: Two hundred and twenty-one patients undergoing on-pump coronary artery bypass graft surgeries were evaluated prospectively during a 30-day postoperative follow-up period. Serum B-type natriuretic peptide concentration was measured without a 24-hour period prior to the surgical procedure and the value obtained was correlated with a short-term all-cause mortality. Results: Data analysis showed that all-cause mortality rates were equal to 9.5% in 30 days. Accuracy analysis by the receiver operating characteristic curve found an ideal cut-off value of B-type natriuretic peptide equal to 150 pg/mL in relation to mortality (AUC=0.82, 95% CI=0.71-0.87, P<0.001). Multivariate analysis showed that B-type natriuretic peptide value greater than or equal to 150 pg/mL (P=0.030, HR=3.99, 95% CI=1.14-13.98) was an independent predictor of all-cause mortality in a 30-day follow-up period. Conclusion: Preoperative serum B-type natriuretic peptide concentration is an independent predictor of short-term all-cause mortality in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.</p></div>